Capstone Infrastructure Corporation Reports First Quarter Results and Declares a Quarterly Dividend

Written by Customer Service on May 12, 2021. Posted in Dividend Reports And Estimates.

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) — Capstone Infrastructure Corporation (TSX: CSE.PR.A) (the “Corporation” or “Capstone”) today announced and filed its financial results for the first quarter ended March 31, 2021. The Corporation’s Management’s Discussion and Analysis (“MD&A”) for the first quarter 2021 and unaudited interim consolidated financial statements are available at www.capstoneinfrastructure.com and on SEDAR at www.sedar.com. Capstone’s MD&A details the “Results of Operations” and provides a “Financial Position Review” for the quarter ended March 31, 2021. Dividend Declarations The Board of Directors today declared a quarterly dividend on the Corporation’s Cumulative Five-Year Rate Reset Preferred Shares, Series A (the “Preferred Shares”)...

Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy

Written by Customer Service on May 12, 2021. Posted in Public Companies.

LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) — Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the release of preliminary data relating to the use of a novel cell therapy approach in controlling human immunodeficiency virus (HIV) in humans. Dr. Serhat Gumrukçu, co-founder and inventor of Enochian BioSciences and Director of the Seraph Research Institute (SRI), presented the findings at the Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). Presentation can be found at https://www.enochianbio.com/about-us/collaborations/ A 54-year-old man, diagnosed with HIV in 1986, had persistent HIV detected in his blood, despite antiretroviral therapy. With approval from an Institutional Review Board, this single patient was treated...

Ascendis Pharma A/S Announces Expansion of Global Clinical Reach for TransCon™ PTH with Filing of the Clinical Trial Notification for Phase 3 Clinical Trial in Adults with Hypoparathyroidism in Japan

Written by Customer Service on May 12, 2021. Posted in Public Companies.

– Marks next step to bring the potential first ever hormone replacement therapy for hypoparathyroidism to Japan – COPENHAGEN, Denmark, May 12, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced that it has filed a Clinical Trial Notification (CTN) with the Pharmaceuticals and Medical Devices Agency (PDMA) in Japan to initiate the company’s phase 3 clinical trial of TransCon PTH in adult subjects with hypoparathyroidism (HP), the PaTHway Japan Trial. “The CTN filing for TransCon PTH represents another milestone as we continue to lay the groundwork to make this important therapy available globally to address a significant unmet need for patients with hypoparathyroidism...

POCML 5 Inc. Announces Conditional Approval of Its Qualifying Transaction With Collective Mining Inc. and Filing of Filing Statement

Written by Customer Service on May 12, 2021. Posted in Mergers And Acquisitions.

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) — POCML 5 Inc. (“POCML5” or the “Company”) (TSXV: PCML.P) is pleased to announce that the TSX Venture Exchange (the “TSXV”) has conditionally accepted its proposed qualifying transaction pursuant to Policy 2.4 – Capital Pool Companies of the TSXV (the “Transaction”) with Collective Mining Inc. (“Collective”), which, upon completion, will result in a reverse take-over of POCML5 by the shareholders of Collective. A filing statement dated May 12, 2021 (the “Filing Statement“) has been prepared in respect of the Transaction in accordance with the requirements of the TSXV and has been filed under POCML5’s issuer profile on SEDAR at www.sedar.com. Collective is an exploration and development company focused on identifying and exploring prospective gold projects in South America. Collective...

EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update

Written by Customer Service on May 12, 2021. Posted in Public Companies.

– PP-001: proof-of-concept study in Austria for dry eye patients expected to initiate in Q3:21; U.S. IND submission planned in Q4:21- -OBG: U.S. IND submission and initiation of Phase 2 dry eye study is planned in Q4:21; proof-of-concept study for persistent epithelial defects expected to initiate in Q4:21- -PP-001 for systemic indications: Phase 1 healthy volunteer study in Austria planned to initiate in Q4:21- WALTHAM, Mass., May 12, 2021 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and certain systemic diseases, today reported its financial results for the quarter ended March 31, 2021 and provided an update on recent corporate and operational...

Trean Insurance Group Reports First Quarter 2021 Results

Written by Customer Service on May 12, 2021. Posted in Public Companies.

– 36% Year-over-Year Growth in First Quarter 2021 Gross Written Premiums to $146.7 Million – – 83% Year-over-Year Growth in First Quarter Net Earned Premium to $41.1 Million – – Net Income of $6.8 Million, Diluted Earnings per Share of $0.13 – – Adjusted Net Income of $8.0 Million, Adjusted Diluted Earnings per Share of $0.16 – WAYZATA, Minn., May 12, 2021 (GLOBE NEWSWIRE) — Trean Insurance Group, Inc. (Nasdaq: TIG) (“Trean” or the “Company”), a leading provider of products and services to the specialty insurance market, today reported results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights Gross written premiums increased 36.0% to $146.7 million, compared to $107.9 million in the first quarter of 2020 Net earned premiums increased 83.2% to $41.1 million,...

Amdocs acquires Sourced to Further Boost Communications Industry’s Move to the Cloud

Written by Customer Service on May 12, 2021. Posted in Mergers And Acquisitions.

Deal expands Amdocs’ portfolio of market-leading cloud-native products and services; brings Sourced’s decade-long experience of delivering cloud at scale ST. LOUIS, May 12, 2021 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced it has acquired Sourced Group, a leading global technology consultancy specializing in large-scale cloud transformations for sophisticated, high-end enterprises in industries such as financial services, communications and others. The two companies are excited by the opportunity to strengthen Amdocs’ capabilities for taking the communications industry to the cloud and bring to Amdocs’ 350+ service provider customers Sourced’s decade-long experience of delivering cloud at scale. “We are delighted the innovative Sourced...

KRONOS ADVANCED TECHNOLOGIES ANNOUNCES BREAKTHROUGH INVISIBLE E-MASK ™

Written by Customer Service on May 12, 2021. Posted in Public Companies.

Los Angeles, Ca, May 12, 2021 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), an innovation-driven product development and production company that has significantly changed the way air is moved, filtered, and sterilized introduced today a breakthrough product, Invisible e-mask™ X3000 This new TSA and FAA-approved device uses electrostatic molecular air purification to create a 3.3 cubic ft zone of cleaner, safer air for breathing. This AIR5G® personal e-mask generates a stream of tens of millions of negative ions that attach to airborne pollutants—such as viruses, bacteria, pollens, and dust— and cause all pollutants to settle away from other persons breathing space. This drastically reduces the number of harmful pathogens in your way and leaves you with...

ISC Announces Results of Annual Meeting of Shareholders

Written by Customer Service on May 12, 2021. Posted in Public Companies.

REGINA, Saskatchewan, May 12, 2021 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) today announced the voting results from its annual meeting of shareholders (the “Meeting”) held on May 12, 2021 in Regina, Saskatchewan. A total of 10,686,203 Class A Limited Voting Shares were represented at the Meeting, being 61.06 per cent of the Company’s issued and outstanding Class A Limited Voting Shares. Shareholders voted in favour of all matters, including the appointment of Deloitte LLP as auditor for the ensuing year and the election of its Board of Directors. Director Voting The following three members of the Board were appointed by the Lieutenant Governor In Council of the Province of Saskatchewan in lieu of Crown Investments Corporation of Saskatchewan (CIC) voting its shares on any resolution...

Martinrea International Inc. to Present at the RBC Capital Markets Canadian Automotive, Industrials and Transportation Conference

Written by Customer Service on May 12, 2021. Posted in Public Companies.

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) — Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, today announced Rob Wildeboer, Executive Chairman, Pat D’Eramo, President and Chief Executive Officer and Fred Di Tosto, Chief Financial Officer will present at the RBC Capital Markets Canadian Automotive, Industrials & Transportation Conference (Virtual Format) on May 17, 2021. Messrs. Wildeboer, D’Eramo and Di Tosto will be speaking on the Company’s general business and strategy as outlined in the Company’s investor presentation posted on www.martinrea.com and in the Company’s most recent public filings, available on www.sedar.com. About Martinrea International Inc. Martinrea...

Day: May 12, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice